BU-NOT-SET

CONTACT US
COVID-19: a year of unprecedented change
  • Industry trends
Eyes
Insight
Oral solids: market and technology trends
  • Drug product
Eyes
Insight
Oral modified release
  • Drug product
Granules
Fact sheet
Semi-solids an overview of current regulatory requirement
  • Drug product
Tube cream
Fact sheet
API relocation strategies for CDMO’s
  • Drug substance
Eyes
Insight
Clinical trial material
  • Drug product
  • Manufacturing
hand scooping pills
Fact sheet
Time and cost-effective solubility improvement
  • Drug substance
Eyes
Insight
Dosage form development trends and technologies
  • Drug product
Eyes
Insight
Vaccine Development and Manufacturing
  • Drug product
  • Manufacturing
Eyes
Insight
Insight
  • Manufacturing
When OSD manufacturing goes global
Insight
  • Drug product
  • Manufacturing
Ensuring Reliable HPAPI Supply
Insight
  • Drug product
  • Manufacturing
De-risking high-potency programmes
Case study
  • Analytical chemistry
  • Drug product
Analytical method development for multivitamin tablets
Insight
  • Drug product
  • Manufacturing
The evolving OSD market: Complexity, capability and collaboration
Insight
  • Drug product
  • Manufacturing
High-potency APIs and the evolving demands of drug development
White paper
  • Drug product
  • Manufacturing
Safely scaling high potency API manufacturing
Insight
  • Drug product
  • Manufacturing
From development insight to manufacturing confidence
Insight
  • Biologics
  • Manufacturing
Recipharm Advanced Bio Is Advancing RNA Therapeutics